157 related articles for article (PubMed ID: 38179572)
1. Hepatitis B immunization status and risk factors of people aged 1 to 69 in Huangpu District, Shanghai, China.
Wang Y; Shu M; Chen J; Shen F; Ren H; Yu Y
Front Public Health; 2023; 11():1302183. PubMed ID: 38179572
[TBL] [Abstract][Full Text] [Related]
2. Epidemiological serosurvey of hepatitis B virus among children aged 1-14 years in Guangdong Province, China.
Zhu Q; Shao X; Chen S; Li D; Chen X; Liu W; Wu X; Jian Z; Rutherford S; Zheng H
Int J Infect Dis; 2018 Jun; 71():25-29. PubMed ID: 29408358
[TBL] [Abstract][Full Text] [Related]
3. The Prevalence of HBV Infection: A Retrospective Study of 13 Years in a Public Hospital of Northeast China.
Jin Y; Geng N; Zhao L; Li Y; Zheng L; Zhu W; Sheng Q; An Z; Wang J; Dou X; Bai H
Viral Immunol; 2020 Mar; 33(2):99-104. PubMed ID: 31834847
[TBL] [Abstract][Full Text] [Related]
4. Post-vaccination serologic testing of infants born to hepatitis B surface antigen positive mothers in 4 provinces of China.
Wang F; Zhang G; Zheng H; Miao N; Shen L; Wang F; Dong P; Du F; Chen C; Zhang X; Cui F
Vaccine; 2017 Jul; 35(33):4229-4235. PubMed ID: 28651839
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of some hepatitis B virus markers among pregnant women attending antenatal clinic in Specialist Hospital Sokoto Nigeria.
Erhabor O; Mohammad SY; Bello L; Onuigwe FU; Abdulrahman Y; Zama I; Buhari H; Bagudo A; Ibrahim K; Ahmed M; Udomah FP; Adias TC; Erhabor T; Okara GC
Hum Antibodies; 2020; 28(3):233-243. PubMed ID: 32333583
[TBL] [Abstract][Full Text] [Related]
6. [Preliminary analysis on the prevalence and causes of breakthrough hepatitis B virus infection among children in Shandong province, China].
Zhang L; Yan BY; Li MS; Song LZ; Lü JJ; Xu Q; Xu AQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Oct; 47(10):933-9. PubMed ID: 24378135
[TBL] [Abstract][Full Text] [Related]
7. Markers of hepatitis B infection in Tari District, Southern Highlands Province, Papua New Guinea.
Sanders RC; Lewis D; Dyke T; Alpers MP
P N G Med J; 1992 Sep; 35(3):197-201. PubMed ID: 1296422
[TBL] [Abstract][Full Text] [Related]
8. [The epidemiological characteristics of HBV susceptibility in 1-29 years old young people in China in 2006 and 2014: based on the national sero-survey data analysis].
Zheng H; Wang FZ; Zhang GM; Miao N; Sun XJ; Cui FQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jul; 51(7):581-586. PubMed ID: 28693080
[No Abstract] [Full Text] [Related]
9. Hepatitis B virus vaccination and antenatal transmission of HBV markers to neonates.
Vranckx R; Alisjahbana A; Meheus A
J Viral Hepat; 1999 Mar; 6(2):135-9. PubMed ID: 10607224
[TBL] [Abstract][Full Text] [Related]
10. Veterans health administration hepatitis B testing and treatment with anti-CD20 antibody administration.
Hunt CM; Beste LA; Lowy E; Suzuki A; Moylan CA; Tillmann HL; Ioannou GN; Lim JK; Kelley MJ; Provenzale D
World J Gastroenterol; 2016 May; 22(19):4732-40. PubMed ID: 27217704
[TBL] [Abstract][Full Text] [Related]
11. Antibody titration and immune response of Iranian beta-thalassemic patients to hepatitis B virus vaccine (booster effect).
Azarkeivan A; Karimi G; Shaiegan M; Maghsudlu M; Tabbaroki A
Pediatr Hematol Oncol; 2009 Jun; 26(4):195-201. PubMed ID: 19437322
[TBL] [Abstract][Full Text] [Related]
12. Kidney Transplantation From Hepatitis B Surface Antigen (HBsAg)-Positive Living Donors to HBsAg-Negative Recipients: Clinical Outcomes at a High-Volume Center in China.
Wang XD; Liu JP; Song TR; Huang ZL; Fan Y; Shi YY; Chen LY; Lv YH; Xu ZL; Li XH; Wang L; Lin T
Clin Infect Dis; 2021 Mar; 72(6):1016-1023. PubMed ID: 32100025
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B surface antigen seroprevalence among pre- and post-vaccine cohorts in Cambodia, 2017.
Ork V; Woodring J; Shafiqul Hossain M; Wasley A; Nagashima S; Yamamoto C; Chuon C; Sugiyama A; Ohisa M; Akita T; Ko K; Mao B; Tanaka J
Vaccine; 2019 Aug; 37(35):5059-5066. PubMed ID: 31285088
[TBL] [Abstract][Full Text] [Related]
14. [Seroepidemiological analysis of hepatitis B virus infection among adolescents aged 0-14 years in Henan Province and preliminary evaluation of the effectiveness of childhood hepatitis B vaccine immunization program].
Guo YH; Chen YP; Dou QH; Liu Q; Yang JH; Seng MH; Lyu YY; Wang CS; Lu MX; Xu J; Zhang YY; Zhao DY
Zhonghua Yu Fang Yi Xue Za Zhi; 2024 Feb; 58(2):202-207. PubMed ID: 38387951
[No Abstract] [Full Text] [Related]
15. Hepatitis B virus (HBV) serological patterns among the HBsAg negative hospital attendees screened for immunization.
Kafeero HM; Ndagire D; Ocama P; Kato CD; Wampande E; Walusansa A; Kajumbula H; Kateete D; Sendagire H
Sci Rep; 2022 May; 12(1):7425. PubMed ID: 35523938
[TBL] [Abstract][Full Text] [Related]
16. Assessing the impact of the routine childhood hepatitis B immunization program and the need for hepatitis B vaccine birth dose in Sierra Leone, 2018.
Breakwell L; Marke D; Kaiser R; Tejada-Strop A; Pauly MD; Jabbi S; Yambasu S; Kabore HJ; Stewart B; Sesay T; Samba TT; Hayden T; Kamili S; Jambai A; Drobeniuc J; Singh T; Tohme RA; Wasley A
Vaccine; 2022 Apr; 40(19):2741-2748. PubMed ID: 35361502
[TBL] [Abstract][Full Text] [Related]
17. Residual risk of mother-to-child transmission of HBV despite timely Hepatitis B vaccination: a major challenge to eliminate hepatitis B infection in Cambodia.
E B; Ko K; Kim R; Nagashima S; Ouoba S; Hussain MRA; Sato T; Chuon C; Abe K; Sugiyama A; Takahashi K; Akita T; Tung R; Ork V; Hossain MS; Saphonn V; Tanaka J
BMC Infect Dis; 2023 Apr; 23(1):261. PubMed ID: 37101167
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B vaccination in children: the Taiwan experience.
Ni YH; Chen DS
Pathol Biol (Paris); 2010 Aug; 58(4):296-300. PubMed ID: 20116181
[TBL] [Abstract][Full Text] [Related]
19. Progress Toward Hepatitis B Control and Elimination of Mother-to-Child Transmission of Hepatitis B Virus - Western Pacific Region, 2005-2017.
Woodring J; Pastore R; Brink A; Ishikawa N; Takashima Y; Tohme RA
MMWR Morb Mortal Wkly Rep; 2019 Mar; 68(8):195-200. PubMed ID: 30817746
[TBL] [Abstract][Full Text] [Related]
20. Seroepidemiological study of hepatitis B virus markers in Japan.
Kiyohara T; Ishii K; Mizokami M; Sugiyama M; Wakita T
Vaccine; 2015 Nov; 33(45):6037-42. PubMed ID: 26341564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
